Table 3 Complications and expenditures for adults with type 2 diabetes receiving diabetes medications
From: Type 2 diabetes detection and management among insured adults
National metrics | Total insured | Commercial | Medicare | Medicaid |
|---|---|---|---|---|
Controlled diabetes | 7,440,000 | 3,480,000 | 3,270,000 | 690,000 |
 Controlled (%) | 57% | 59% | 56% | 58% |
 Presence of diabetes sequelae | ||||
  Neurological complications | 24% | 12% | 36% | 17% |
  Peripheral vascular disease | 19% | 8% | 32% | 12% |
  Cardiovascular disease | 80% | 71% | 93% | 61% |
  Renal complications | 28% | 17% | 40% | 20% |
  Endocrine/metabolic complications | 72% | 70% | 81% | 38% |
  Ophthalmic complications | 35% | 21% | 51% | 22% |
  Other complications | 17% | 14% | 20% | 19% |
  Foot problems | 7% | 3% | 10% | 7% |
 Total expenditures | $17,500 | $13,160 | $21,280 | $19,000 |
  Medical expenditures | $12,980 | $9,630 | $15,900 | $14,110 |
  Rx expenditures | $4,520 | $3,530 | $5,380 | $4,890 |
Uncontrolled diabetes | 5,550,000 | 2,450,000 | 2,590,000 | 510,000 |
 Uncontrolled (%) | 43% | 41% | 44% | 42% |
 Presence of diabetes sequelae | ||||
  Neurological complications | 38% | 23% | 52% | 31% |
  Peripheral vascular disease | 30% | 13% | 46% | 20% |
  Cardiovascular disease | 88% | 80% | 96% | 76% |
  Renal complications | 42% | 27% | 56% | 33% |
  Endocrine/metabolic complications | 82% | 82% | 88% | 51% |
  Ophthalmic complications | 43% | 28% | 58% | 33% |
  Other complications | 30% | 24% | 34% | 35% |
  Foot problems | 12% | 7% | 17% | 12% |
 Total expenditures | $22,410 | $19,730 | $24,440 | $23,490 |
  Medical expenditures | $17,140 | $14,880 | $18,900 | $17,830 |
  Rx expenditures | $5,270 | $4,850 | $5,540 | $5,660 |
Uncontrolled impact (percentage point or $ change) | ||||
 Presence of diabetes sequelae | ||||
  Neurological complications | 14% | 11% | 16% | 14% |
  Peripheral vascular disease | 11% | 5% | 14% | 8% |
  Cardiovascular disease | 8% | 9% | 4% | 15% |
  Renal complications | 14% | 10% | 16% | 13% |
  Endocrine/metabolic complications | 10% | 12% | 7% | 13% |
  Ophthalmic complications | 8% | 7% | 7% | 11% |
  Other complications | 13% | 10% | 14% | 16% |
  Foot problems | 5% | 3% | 7% | 6% |
 Total expenditures | $4,910 | $6,570 | $3,160 | $4,490 |
  Medical expenditures | $4,160 | $5,250 | $3,000 | $3,720 |
  Rx expenditures | $750 | $1,320 | $160 | $770 |
Controlled (age-sex-adjusted to uncontrolled population) | ||||
 Total expenditures | $17,550 | $13,050 | $21,010 | $19,130 |
  Medical expenditures | $12,990 | $9,560 | $15,630 | $14,170 |
  Rx expenditures | $4,560 | $3,490 | $5,380 | $4,960 |
Uncontrolled impact (age-sex-adjusted) | ||||
 Total expenditures | $4,860 | $6,680 | $3,430 | $4,360 |
  Medical expenditures | $4,150 | $5,320 | $3,270 | $3,660 |
  Rx expenditures | $710 | $1,360 | $160 | $700 |